Sceening Technologies Branch

Description:

For More Information About This Series Contact:
Pam Young
Phone: 301-846-5875
E-Mail:
Web:

Series Calendar:
7/16/2008	Eileen White, Ph.D.	Role of Autophagy in Cancer and Treatment
1/23/2008	Angelika Burger, PhD, University of Maryland, School of Medicine	Cancer Stem Cells-Therapeutic Implications
10/31/2007	Dr. Waldemar Priebe	Chemistry (Chemist?) Inspired/Led Anticancer Drug Discovery and Development
11/30/2005	Robert A. Kramer, Ph.D.	The Evolution of Small Molecule Kinase Inhibitors
10/26/2005	Guy T. Carter, Ph.D.	Exploiting Marine Microbial Biodiversity in a Modern Natural Products Drug Discovery Program
6/8/2005	Peter J. Houghton, Ph.D	The Pediatric Preclinical Testing Program: An NCI Initiative to Identify Active Agents for Treatment of Childhood Cancer
5/25/2005	Gregg L. Semenza, M.D.,Ph.D., Director, Vascular Program	Overexpression of HIF-1 in Human Cancer: Mechanisms and Consequences
5/11/2005	Dr. David Piwnica-Worms	Imaging Signal Transduction and Protein-Protein Interactions in Vivo With Genetically Encoded Reporters
4/27/2005	Dr. Lee J. Helman, M.D.	mTOR Molecular Determinant of Aggressive Behavior in Sarcomas
4/6/2005	Dr. Chris H. Takimoto	Dual Kinase Inhibitors: Clinical Studies With AEE788, A Multi-targeted Tyrosone Kinase Inhibitor
3/9/2005	Dr. Dietmar Siemann, Ph.D.	Vascular Targeting Approaches in Cancer Therapy
2/23/2005	Panos Z. Anastasiadis, Ph.D.	Roles of p120 Catenin in Intercellular Adhesion and Metastasis